Granules Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 250.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 225.00 Cr
as on 12-12-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 400.00 Cr
as on 12-12-2024
- Revenue 71.69%
(FY 2024)
- Profit -335.20%
(FY 2024)
- Ebitda -271.34%
(FY 2024)
- Net Worth 275.75%
(FY 2024)
- Total Assets 333.91%
(FY 2024)
About Granules Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 250.00 Cr and a paid-up capital of Rs 225.00 Cr.
The company currently has active open charges totaling ₹400.00 Cr.
The Key Managerial Personnel (KMP) at Granules Life Sciences Private Limited India are Mukesh Surana as CFO and Anshuman Gupta as Company Secretary. Chigurupati Prasad, Umadevi Chigurupati, and Rajiv Kakodkar serve as directors at the Company.
- CIN/LLPIN
U24290TG2020PTC146042
- Company No.
146042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2020
- Date of AGM
27 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Granules Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Surana  | CFO | 19-Apr-2024 | Current |
| Anshuman Gupta | Company Secretary | 31-Mar-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Kakodkar | Additional Director | 19-Apr-2024 | Current |
| Chigurupati Prasad | Director | 18-Nov-2020 | Current |
| Umadevi Chigurupati | Additional Director | 19-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Granules Life Sciences.
Granules Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 71.69% increase. The company also saw a substantial fall in profitability, with a 335.2% decrease in profit. The company's net worth Soared by an impressive increase of 275.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Granules Life Sciences?
In 2024, Granules Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krsma Vineyards Private LimitedActive 16 years 9 monthsChigurupati Prasad and Umadevi Chigurupati are mutual person
- Krsma Estates Private LimitedActive 17 years 2 months
Chigurupati Prasad and Umadevi Chigurupati are mutual person
Granules India LimitedActive 33 years 9 monthsChigurupati Prasad, Umadevi Chigurupati and 2 more are mutual person
Triton Securities LlpActive 7 years 9 monthsChigurupati Prasad and Umadevi Chigurupati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sbicap Trustee Company Limited Creation Date: 20 Feb 2024 | ₹400.00 Cr | Open |
How Many Employees Work at Granules Life Sciences?
Unlock and access historical data on people associated with Granules Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Granules Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Granules Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
